TCTMD

Syntax Score Predicts 1-Year Risk in ACS Patients

In patients with moderate- and high-risk acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI), the Syntax score predicts 1-year ischemic outcomes including mortality, ...
Medscape

Three-Year SYNTAX Results Extend CABG Advantage to Intermediate-Risk Patients

September 13, 2010 (Geneva, Switzerland) — Three-year results for the landmark SYNTAX trial are bringing some clarity to a finding just hinted at--then strenuously debated--at the two-year mark: ...
TCTMD

ACUITY Substudy: Syntax Score Correlates with Stent Thrombosis in NSTE-ACS Patients

The extent and severity of disease, as assessed by Syntax score, strongly correlates with the risk of stent thrombosis at 30 days and 1 year in patients with non-ST-segment elevation acute coronary ...
Medscape

Surgery Is Best for Most Patients, Final SYNTAX Data Confirm

BARCELONA — Final, five-year results from the SYNTAX trial comparing CABG surgery and PCI with a drug-eluting stent (DES) in patients with complex coronary disease confirm the message that started to ...
Nature

Logistic Clinical SYNTAX score

The SYNTAX score is an anatomical-based tool that has quickly become established for long-term risk prediction after percutaneous coronary intervention (PCI). Since publication of the SYNTAX trial, Dr ...